KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Cash & Current Investments: 2009-2024

Historic Cash & Current Investments for Novavax (NVAX) over the last 16 years, with Dec 2024 value amounting to $923.1 million.

  • Novavax's Cash & Current Investments fell 16.12% to $762.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year increase of 0.72%. This contributed to the annual value of $923.1 million for FY2024, which is 62.38% up from last year.
  • Per Novavax's latest filing, its Cash & Current Investments stood at $923.1 million for FY2024, which was up 62.38% from $568.5 million recorded in FY2023.
  • In the past 5 years, Novavax's Cash & Current Investments ranged from a high of $1.5 billion in FY2021 and a low of $568.5 million during FY2023.
  • Moreover, its 3-year median value for Cash & Current Investments was $923.1 million (2024), whereas its average is $942.8 million.
  • As far as peak fluctuations go, Novavax's Cash & Current Investments spiked by 802.08% in 2020, and later crashed by 57.48% in 2023.
  • Novavax's Cash & Current Investments (Yearly) stood at $711.0 million in 2020, then surged by 113.08% to $1.5 billion in 2021, then decreased by 11.76% to $1.3 billion in 2022, then slumped by 57.48% to $568.5 million in 2023, then surged by 62.38% to $923.1 million in 2024.